The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1-benzyl-4-(phenylamino)piperidin-4-yl)methyl)-2-guanidinoacetamide ID: ALA3361416
PubChem CID: 118724977
Max Phase: Preclinical
Molecular Formula: C22H30N6O
Molecular Weight: 394.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCC(=O)NCC1(Nc2ccccc2)CCN(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C22H30N6O/c23-21(24)25-15-20(29)26-17-22(27-19-9-5-2-6-10-19)11-13-28(14-12-22)16-18-7-3-1-4-8-18/h1-10,27H,11-17H2,(H,26,29)(H4,23,24,25)
Standard InChI Key: JOTDNJDIGBWICX-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
17.5941 -4.7985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5930 -3.9735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8790 -4.3870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1805 -5.5124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5918 -6.2227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4126 -6.2263 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8262 -5.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4190 -4.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8230 -6.9420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4082 -7.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5832 -7.6508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1687 -8.3632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5791 -9.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4083 -9.0798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8192 -8.3668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1652 -4.8004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4528 -4.3849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7393 -4.7977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7401 -5.6235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4601 -6.0349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1706 -5.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3043 -3.5548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3002 -2.7298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0126 -2.3136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5836 -2.3209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7292 -2.7226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4415 -2.3065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1581 -2.7153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4374 -1.4814 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
1 3 1 0
1 4 1 0
1 8 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
6 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
3 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
2 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
26 27 1 0
27 28 1 0
27 29 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.52Molecular Weight (Monoisotopic): 394.2481AlogP: 1.73#Rotatable Bonds: 8Polar Surface Area: 106.27Molecular Species: BASEHBA: 4HBD: 5#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 11.10CX LogP: 0.89CX LogD: -2.73Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.35Np Likeness Score: -0.79
References 1. Journigan VB, Mésangeau C, Vyas N, Eans SO, Cutler SJ, McLaughlin JP, Mollereau C, McCurdy CR.. (2014) Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors., 57 (21): [PMID:25268943 ] [10.1021/jm500989n ]